February 24 2025 - Sanofi shows how $500M bowel disease bet compares to Merck and Roche's rival assets

Sanofi shows how $500M bowel disease bet compares to Merck and Roche's rival assets
FDA approves Medtronic’s adaptive deep-brain stimulator for Parkinson’s disease
Pfizer inks deal to test Summit’s white-hot bispecific with ADCs
Amgen plans $200M investment in India site
*please scroll down for all the latest news*

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud